RNA modification m⁶A emerges as key player in cancer development and therapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Dec-2025 21:11 ET (31-Dec-2025 02:11 GMT/UTC)
In a review published in Molecular Biomedicine, a team of Chinese scientists summarizes the pivotal role of N⁶-methyladenosine (m⁶A)—the most abundant chemical modification in eukaryotic mRNA—in cancer biology. The authors describe how m⁶A regulators (writers, erasers, and readers) influence tumor progression, metastasis, treatment resistance, and the tumor microenvironment. They also discuss emerging therapeutic strategies, including small-molecule inhibitors, RNA-based editing technologies, and combination therapies, highlighting m⁶A's potential as a diagnostic and prognostic biomarker and a target for precision oncology.
In a comprehensive review published in MedComm - Oncology, a research team sheds new light on the complex biology and therapeutic challenges of breast cancer brain metastasis (BCBrM). The authors detail the multi-step metastatic cascade, from primary tumor invasion to brain colonization, and highlight key signaling pathways such as TGF-β, Wnt/β-catenin, PI3K/AKT, Notch, HER2-HER3, and JAK/STAT. They also explore the dynamic interactions between tumor cells and the brain microenvironment, including astrocytes, microglia, and neurons, which facilitate immune evasion and metabolic adaptation. The review further discusses advances in preclinical models, emerging CNS-penetrant therapies, and innovative clinical trial designs, offering a roadmap for personalized management of BCBrM.
New research has found that social interactions among meerkats may be crucial to their health and survival – thanks to the sharing of beneficial gut bacteria.